Clinical trial
Interferon ß-1b Treatment by Cyclical Administration
NCT00270816 · S. Andrea Hospital, Other · Completed
Key facts
| NCT number | NCT00270816 |
|---|---|
| Title | Interferon ß-1b Treatment by Cyclical Administration |
| Official title | Effect of Cyclical Administration of Interferon β-1b in Multiple Sclerosis - Comparison With Normal Dose. |
| Lead sponsor | S. Andrea Hospital, Other |
| Collaborators | Italian Multiple Sclerosis Foundation |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Interferon-ß-1b, Interferon ß-1b |
| Enrollment | 60 |
| Start date | Nov 1, 2005 |
| Primary completion | Aug 1, 2010 |
| Completion | Jan 1, 2011 |
| First posted | Dec 28, 2005 |
| Last update posted | Dec 19, 2018 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: